MedPath

Influence of Moderate Inspired Oxygen Fraction (FiO2) and Protective Ventilation on Postoperative Pulmonary Complication

Phase 4
Conditions
Hepatectomy
Registration Number
NCT02198625
Lead Sponsor
Fenmei Shi
Brief Summary

The purpose of this study is to determine the influence of moderate FiO2 and the lung protective ventilation on postoperative pulmonary complications following hepatic resection surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
280
Inclusion Criteria
  • ASA 1~2,Planned intrabdominal hepatic resection surgery;
  • Expected duration 2 hours to 6 hours;
  • Age 40 yr to 70 yr);
  • BMI 18-26.9kg/m2
  • Risk of postoperative pulmonary complications (Arozullah score ≥2);
Exclusion Criteria
  • Noninvasive ventilation in the last 30 days;
  • Recent history of pneumonia, ALI/ARDS (in the last 30 days);
  • History of pulmonary resection;
  • History of neuromuscular disease;
  • Child-Pugh>A grade;
  • Patient refusal;

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
a composite of pulmonary and extrapulmonary complications occurring by day 7 after surgery.during the first seven days after surgery

The primary outcome was a composite of major pulmonary complications (defined as pneumonia or need for invasive or noninvasive ventilation for acute respiratory failure) and extrapulmonary complications (defined as sepsis, septic shock, or death) within the first 7 days after surgery.

Secondary Outcome Measures
NameTimeMethod
incidence of pulmonary complicationswithin the 30-day follow-up period

the incidence of pulmonary complications due to any cause, graded on a scale from 0 (no pulmonary complications) to 4 (the most severe complications);extrapulmonary complications; durations of ICU and hospital stays;

Oxidative stress markers2 days

Oxidative stress markers variation in blood before anesthesia,during and after surgery , and compare with controls.

Trial Locations

Locations (1)

First Affiliated Hospital, Sun Yat-Sen University

🇨🇳

Guangzhou, Guangdong, China

First Affiliated Hospital, Sun Yat-Sen University
🇨🇳Guangzhou, Guangdong, China
Ying Xiao, MD,PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.